Streamline Health Solns Q2 EPS $(0.04) Beats $(0.05) Estimate, Sales $5.77M Miss $5.99M Estimate
Portfolio Pulse from Benzinga Newsdesk
Streamline Health Solns (NASDAQ:STRM) reported Q2 earnings per share of $(0.04), beating the analyst consensus estimate of $(0.05) by 20%. However, the company's quarterly sales of $5.77 million missed the analyst consensus estimate of $5.99 million by 3.67%.
September 13, 2023 | 8:19 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Streamline Health Solns reported better than expected Q2 earnings per share but missed on sales.
Streamline Health Solns reported a better than expected earnings per share for Q2, which could positively impact the stock. However, the company missed on sales, which could negatively impact the stock. The net effect is likely to be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100